Article feature image

Ocular Therapeutix, Inc. (OCUL) CEO Antony Mattessich on Q3 2021 Results – Earnings Call Transcript

Stock Analysis

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET
Company Participants
Antony Mattessich – CEO
Donald Notman – CFO
Dr. Michael Goldstein – Chief Medical Officer
Scott Corning – Senior Vice President Commercial
…

Click here to view the original article.

Tags:
, ,
Facebook Google+ Twitter Pinterest

Related Posts